Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial

Biteker, Murat; Duran, Nilufer; Kaya, Hasan; Gunduz, Sabahattin; Tanboga, Halil; Gokdeniz, Tayyar; Kahveci, Gokhan; Akgun, Taylan; Yildiz, Mustafa; Ozkan, Mehmet

doi:10.1007/s00392-010-0279-7

Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial

Atıf İçin Kopyala

Biteker M., Duran N. E. , Kaya H., Gunduz S., Tanboga H. I. , Gokdeniz T., ...Daha Fazla

CLINICAL RESEARCH IN CARDIOLOGY, cilt.100, ss.571-577, 2011 (SCI İndekslerine Giren Dergi)

Cilt numarası: 100 Konu: 7
Basım Tarihi: 2011
Doi Numarası: 10.1007/s00392-010-0279-7
Dergi Adı: CLINICAL RESEARCH IN CARDIOLOGY
Sayfa Sayıları: ss.571-577

Özet

Levosimendan is a promising new inodilator agent but its effectiveness in peripartum cardiomyopathy (PPCM) has not been tested in a clinical trial. The authors sought to evaluate the effect of levosimendan therapy and to determine the predictors of clinical outcome in patients with PPCM.